For example, Fan et al. (2017) showed that subanesthetic ketamine injections (8 mg/kg) produced neuroprotective effects in a mouse model of Parkinson disease (PD), which corresponded with elevated expression of autophagy markers and reduced mTOR activation compared to untreated PD mice. This evidence concerns the gene MTOR and Parkinson disease.